IP Library › Granted Patent US 12,622,966
Granted Patent B2
US 12,622,966 · App. 18/162,658 · Granted May 12, 2026

Compound for photothermal cancer therapy, composition including the same, and method for photothermal cancer therapy

Inventors: Song Yi Lee (Busan, KR); Thanh Chung Pham (Busan, KR)
Assignee: PUKYONG NATIONAL INDUSTRY-UNIVERSITY COOPERATION FOUNDATION
A61K41/0052A61K9/51A61P35/00C07C255/61A61N5/062A61N5/0625A61N2005/0663A61N5/067C07C2602/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,622,966
App. No.
18/162,658
Granted
May 12, 2026
Kind
B2
Abstract

Provided are a new compound for photothermal cancer therapy, a composition including the same, and a method for photothermal cancer therapy, and more particularly, a compound that is an organic photosensitizer based on an indan structure, a nanoparticle as a self-assembly thereof, a composition including the same, and a method for photothermal therapy using the same.

Claims (21)

1 . A compound represented by Chemical Formula 1:

wherein R 1 is selected from a substituted or unsubstituted cycloalkyl group having 3 to 6 carbon atoms, a substituted or unsubstituted cycloalkenyl group having 3 to 6 carbon atoms, a substituted or unsubstituted aryl group having 6 to 12 carbon atoms, a substituted or unsubstituted heteroaryl group having 5 to 12 carbon atoms, an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, and an alkynyl group having 2 to 10 carbon atoms; and

wherein when R 1 is selected from a substituted cycloalkyl group having 3 to 6 carbon atoms, a substituted cycloalkenyl group having 3 to 6 carbon atoms, a substituted aryl group having 6 to 12 carbon atoms, and a substituted heteroaryl group having 5 to 12 carbon atoms, the substitution is selected from one of an alkyl having 1 to 5 carbon atoms, alkenyl having 2 to 5 carbon atoms, alkynyl having 2 to 5 carbon atoms, and a halogen atom.

2 . The compound of claim 1 , wherein the compound is provided in the form of an aggregate nanoparticle.

3 . The compound of claim 2 , wherein

the nanoparticle has a size of 500 nm or less, and

the nanoparticle emits heat at a temperature of 45° C. or higher by a light irradiation.

4 . The compound of claim 2 , wherein a photothermal conversion efficiency of the nanoparticle is 60% or higher.

5 . A composition comprising:

the compound represented by Chemical Formula 1 of claim 1 .

6 . The composition of claim 5 , wherein the composition is used for photothermal therapy, and emits thermal energy during a light irradiation to remove or kill target cells.

7 . The composition of claim 6 , wherein the target cells comprise cancer cells, tumor cells or hyperproliferative cells.

8 . The composition of claim 5 , further comprising:

water, an organic solvent, or both,

wherein the compound in the composition is included in an active ingredient content.

9 . A method for photothermal therapy, the method comprising:

contacting the composition of claim 5 with a target cell in vivo or ex vivo; and

irradiating light to a region of the target cell contacting the composition.

10 . The method of claim 9 , wherein the irradiating of the light comprises heating a target cell region to a temperature of 45° C. or more by irradiating a red light laser of 1 second or more and 1 W/cm 2 or more and removing or killing the target cell.

11 . The method of claim 9 , further comprising:

after the irradiating of the light, acquiring and analyzing an infrared thermal image of the target cell region.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2023
From: LEE, SONG YI; PHAM, THANH CHUNG
To: PUKYONG NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION
Reel/Frame 062554/0057 →
Priority Claims (1)
KR 10-2022-0048172 · Apr 19, 2022 · national
Continuity (1)
Related Publication 20230338538A1 · Oct 26, 2023
References Cited (6)
US 5028708A · Hioki · 1991 [cited by examiner]
US 5220027A · Hioki · 1993 [cited by examiner]
US 6120983A · Okada et al. · 2000 [cited by applicant]
EP 0287377B1 · 1993 [cited by applicant]
Ni, Jen-Shyang , et al., “Photoinduced Nonadiabatic Decay-guided Molecular Motor Triggers Effective Photothermal Conversion for Hyperthermia Cancer Therapy”, Angew. Chem Int. Ed., 59,, 2020, 11298-11302. [cited by applicant]
Tan, Yonghong , et al., “NIR-II Aggregation-Induced Emission Luminogens for Tumor Phototheranostics”, Biosensors, 12,, Jan. 17, 2022. [cited by applicant]